Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PRECISESADS Resource Report Resource Website 10+ mentions |
PRECISESADS (RRID:SCR_003882) | PRECISESADS | organization | A project that will study 2,500 people with various systemic autoimmune diseases (SADs), gathering data on the molecular causes of their disease as well as their clinical symptoms, enabling them to pave the way for a new classification of these diseases. The goal is to use OMICs and bioinformatics to identify new classifications for diseases known to share common pathophysiological mechanisms. Results will be shared to deliver a new molecular taxonomy of systemic autoimmune diseases. In order to achieve this, PRECISEADS is informing on a regular basis on the project implementation and results, and involving stakeholders from Europe in its activities in order to broaden the project impact and increase opportunities for cooperation. | biomarker, diagnostic, basic research, clinical, genomics, transcriptomics, epigenomics, flow cytometry, cellular separations, pre-clinical model, proteomics, metabolomics, serology, tissue, taxonomy, imaging, biosample, sample collection, biobanking, blood, urine |
is listed by: Consortia-pedia is related to: Centre for Genomics and Oncological Research is related to: Progress and Health Foundation; Seville; Spain is related to: Spanish National Research Council; Madrid; Spain is related to: August Pi i Sunyer Biomedical Research Institute; Barcelona; Spain is related to: German Rheumatism Research Centre Berlin; Berlin; Germany is related to: Bellvitge Biomedical Research Institute is related to: Karolinska Institute; Stockholm; Sweden is related to: Hannover Medical School; Lower Saxony; Germany is related to: Medical University of Vienna; Vienna; Austria is related to: Cyprus Institute of Neurology and Genetics; Nicosia; Cyprus is related to: University of Granada; Granada; Spain is related to: University of Milan; Milan; Italy is related to: Catholic University of Louvain; Louvain-la-Neuve; Belgium is related to: University of Western Brittany; Brest; France is related to: University of Geneva; Geneva; Switzerland is related to: University of Szeged; Szeged; Hungary is related to: Althia is related to: Quartz Bio is related to: Catholic University of Leuven; Flemish Brabant; Belgium has parent organization: Progress and Health Foundation; Seville; Spain has parent organization: Centre for Genomics and Oncological Research |
Innovative Medicines Initiative ; EFPIA |
nlx_158209 | SCR_003882 | PRECISESADS - Molecular reclassification to find clinically useful biomarkers for systemic autoimmune diseases | 2026-09-12 12:56:04 | 19 | |||||||
|
ONE Study Resource Report Resource Website 10+ mentions |
ONE Study (RRID:SCR_003886) | ONE Study | consortium, data or information resource, organization portal, portal | Consortium aiming to produce regulatory T cells that are compatible with a kidney transplant patient''''s immune system, as a measure to suppress the body''''s natural immune response against a transplanted organ. If successful, this approach will reduce a transplantation patient''''s life-long dependency on immune suppressing drugs, many of which are often associated with undesirable side effects and can limit the patient''''s daily routine. The consortium goals are to develop and conduct clinical trials of various immunoregulatory T-cell-based products in organ transplantation recipients, allowing a direct comparison of the safety, clinical practicality and therapeutic efficacy of each cell type. The central focus of the project is to: # Production and manufacture of distinct populations of hematopoietic immunoregulatory T cells # Comparatively study the tolerogenic characteristics of these regulatory cell types # Test these cell therapy products side by side in a clinical trial living donor renal transplant recipients The first workstream will work with different T regulatory cell, tolerogenic DC and suppressive macrophage cell products that are currently in development. In addition to these therapeutics, another goal of this workstream is to develop a cell tracking technology that assesses pharmacodynamics and pharmacokinetics of these cell-based therapies. The second workstream is focused on designing and conducting a cell therapy based clinical trial in renal transplantation, taking into consideration ethics, concurrent immunosuppressive drug use, state-of-the-art immune monitoring, innovative all-in-one data capturing systems, and pharmacovigilance. The goal is to have a comparative evaluation of hematopoietic cell therapy safety in renal transplantation. The third workstream aims to learn more about the specific comparative characteristics of suppressive cell types and to use this knowledge to improve later trial designs and foster novel ideas for new or improved suppressive / tolerogenic cell population. | immune response, organ transplant, kidney, clinical trial, cell therapy, clinical, immune system, tool development, basic research, healthcare, drug development, transplant surgery, immunosuppression, hematopoietic immunoregulatory cell |
is listed by: Consortia-pedia is related to: University of Regensburg; Bavaria; Germany is related to: King's College London; London; United Kingdom is related to: University of Oxford; Oxford; United Kingdom is related to: Charite - Universitatsmedizin Berlin; Berlin; Germany is related to: Fondazione Centro San Raffaele; Milan; Italy is related to: Loughborough University; Loughborough; United Kingdom is related to: University of Wisconsin-Madison; Wisconsin; USA is related to: University of California at San Francisco; California; USA is related to: Miltenyi Biotec is related to: Electro Scientific Industries is related to: Beckman Coulter is related to: KOEHLER eClinical is related to: Pharmatching is related to: ALTA |
European Union FP7 | nlx_158215 | SCR_003886 | A Unified Approach to Evaluating Cellular Immunotherapy in Solid Organ Transplantation, The ONE Study - A Unified Approach to Evaluating Cellular Immunotherapy in Solid Organ Transplantation, The ONE Study | 2026-09-12 12:56:04 | 21 | |||||||
|
TRANSFoRm Clinical Data Integration Model Resource Report Resource Website |
TRANSFoRm Clinical Data Integration Model (RRID:SCR_003885) | CDIM | controlled vocabulary, data or information resource, ontology | A global mediation model expressed as an ontology for use in the primary care domain. It uses a realist approach employing Basic Formal Ontology (BFO v1.1) as an upper ontology. Other ontologies were imported or specialized to give deeper definition to the concepts in the domain. These included OGMS, IAO and VSO. The CDIM ontology includes concepts that are especially important to primary care (e.g. episode of care or reason for encounter), but also others to handle temporality in queries (e.g. the start and beginning of processes). The owl file provided for download is the merged file created directly in Prot��g�� through the Refactor/Merge ontologies tool in order to facilitate the load of CDIM in LexEVS for use in the unified interoperability framework. | clinical, primary care, owl, interoperability |
uses: Ontology for General Medical Science uses: Information Artifact Ontology uses: Vital Signs Ontology is used by: TRANSFoRm Data Integration Models has parent organization: TRANSFoRm |
nlx_158222 | SCR_003885 | CDIM ontology, Clinical Data Integration Model | 2026-09-12 12:56:04 | 0 | ||||||||
|
ORBITO Resource Report Resource Website 1+ mentions |
ORBITO (RRID:SCR_003876) | ORBITO | consortium, data or information resource, organization portal, portal | Project that aims to increase understanding of how orally-administered drugs are taken up from the gastrointestinal tract into the body, and apply this knowledge to create new laboratory tests and computer models that will better predict the performance of these drugs in patients over a range of clinically relevant conditions. The integration of in vitro and in silico approaches will provide a biopharmaceutics toolkit, validated using clinical data, to accelerate drug development. Ultimately, the project will help to facilitate and speed up the formulation development process and significantly reduce the need for animal experiments in this area as well as for human clinical studies in the future. For patients, the main benefit will be in the form of high quality medicines where the dose required is well calculated and is released in a way that consistently provides an optimal clinical effect. | drug, drug development, tool development, computer model, drug absorption, oral drug, gastrointestinal tract, clinical, in vivo, in vitro, in silico, biopharmaceutics, dose, drug performance |
is listed by: Consortia-pedia is related to: AbbVie is related to: Janssen Research and Development is related to: Merck is related to: Orion is related to: Pfizer Animal Genetics is related to: Uppsala University; Uppsala; Sweden is related to: University of Copenhagen; Copenhagen; Denmark is related to: University of Greifswald; Mecklenburg-Vorpommern; Germany is related to: Goethe University Frankfurt am Main; Hessen; Germany is related to: Johannes Gutenberg University Mainz; Rhineland-Palatinate; Germany is related to: Catholic University of Leuven; Flemish Brabant; Belgium is related to: Medical Products Agency; Uppsala; Sweden is related to: University of Athens; Athens; Greece is related to: TNO is related to: University of Manchester; Manchester; United Kingdom is related to: University of Strathclyde; Glasgow; United Kingdom is related to: Simcyp is related to: Sirius Analytical is related to: Simulations Plus has parent organization: Uppsala University; Uppsala; Sweden |
Innovative Medicines Initiative ; EFPIA |
nlx_158204 | SCR_003876 | orbito - Innovative Tools for Oral Biopharmaceutics, Oral biopharmaceutics tools (ORBITO) | 2026-09-12 12:56:04 | 7 | |||||||
|
AtheroRemo Resource Report Resource Website 1+ mentions |
AtheroRemo (RRID:SCR_003831) | AtheroRemo | consortium, data or information resource, organization portal, portal | Project targeting vulnerable plaques causing unexpected acute myocardial infarcts and sudden cardiac deaths by identifying and validating novel drug targets as well as devising and validating diagnostic tests. It has been designed to advance the present knowledge on the role of inflammatory remodeling in the different stages of atherosclerosis. It will also provide important knowledge for the development of strategies for prevention and clinical management of vascular diseases. | consortium, drug target, diagnostic test, clinical, plaque, inflammation, functional genomics, target validation, lipidomics | is listed by: Consortia-pedia | European Union FP7 | nlx_158144 | SCR_003831 | AtheroRemo Consortium, European Collaborative Project on Inflamation and Vascular Wall Remodelling in Atherosclerosis - AtheroRemo | 2026-09-12 12:56:03 | 1 | |||||||
|
AddNeuroMed Resource Report Resource Website 50+ mentions |
AddNeuroMed (RRID:SCR_003819) | AddNeuroMed | consortium, data or information resource, database, organization portal, portal | THIS RESOURCE IS NO LONGER IN SERVICE. Documented on January 9,2023. Project portal for a cross European study designed to find biomarkers, or tests, for Alzheimer's disease. Its objectives are to produce and improve experimental models of Alzheimer's for biomarker discovery and to identify a biomarker for Alzheimer's disease suitable for diagnosis, prediction, and monitoring disease progression for use in clinical trials and in clinical practice. The baseline dataset database was scheduled to be completed and locked in 2008 and become available to researchers by 2009. Requests to access the data will be reviewed by the scientific projects committee. | biomarker, test, diagnostic, device, clinical, animal model, clinical trial, pre-clinical, consortium, disease progression, mri, proteomics, genomics, lipidomics, neuroimaging, mouse model, rat model, drosophila model, FASEB list |
is listed by: Consortia-pedia is related to: Innovative Medicines Initiative is related to: University of Eastern Finland at Kuopio; Kuopio; Finland is related to: University of Perugia; Perugia; Italy is related to: Aristotle University of Thessaloniki; Thessaloniki; Greece is related to: King's College London; London; United Kingdom is related to: University of Lodz; Lodz; Poland has parent organization: Innovative Medicines Initiative has parent organization: King's College London; London; United Kingdom |
European Union ; EFPIA |
PMID:19906259 | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_158122 | SCR_003819 | The AddNeuroMed Study | 2026-09-12 12:56:03 | 77 | |||||
|
MRC Cognition and Brain Sciences Unit Resource Report Resource Website 10+ mentions |
MRC Cognition and Brain Sciences Unit (RRID:SCR_003818) | CBU | data or information resource, department portal, organization portal, portal | Unit studying human cognition and the brain with about 90 researchers and postgraduate students investigating topics such as attention, emotion, language and memory. They are developing new treatments for depression, improving hearing through cochlear implants, and helping children to overcome memory problems. With a large collection of scientists engaged in both basic and translational research on the mind and brain, the Unit provides an exceptional training and academic environment that benefits postgraduate students and researchers at all levels. A significant part of their research makes use of brain imaging and they have excellent on-site facilities for magnetic resonance imaging (MRI) magnetoencephalography (MEG) and electroencephalography (EEG). They also have clinical facilities at Addenbrooke's Hospital. The Unit has close links both with the hospital and with Cambridge University. | cognition, attention, language, memory, emotion, behavior, neuroimaging, computer modelling, brain, depressive disorder, hearing, cochlear implant, child, clinical, mri, magnetoencephalography, eeg, ear, cochlea |
has parent organization: University of Cambridge; Cambridge; United Kingdom is parent organization of: CBU Imaging Wiki is parent organization of: Kymata Atlas |
MRC | nlx_158118, grid.415036.5, Wikidata: Q5141152, ISNI: 0000 0001 2177 2032 | https://ror.org/055bpw879 | SCR_003818 | Cognition and Brain Sciences Unit | 2026-09-12 12:56:03 | 33 | ||||||
|
National Kidney Foundation Resource Report Resource Website 10+ mentions |
National Kidney Foundation (RRID:SCR_003990) | NKF | institution | Organization in the U.S. dedicated to the awareness, prevention and treatment of kidney disease. Initiatives include public and professional education, kidney health screenings, research, and patient services. They publish a number of scientific journals including the American Journal of Kidney Diseases, Advances in Chronic Kidney Disease and the Journal of Renal Nutrition. The NKF also publishes the Kidney Dialysis Outcomes Quality Initiative K/DOQI, a comprehensive set of clinical practice guidelines. (Adapted from Wikipedia) | kidney, organ, donation, transplantation, nephrology, clinical, training resource, narrative resource, standard specification | is related to: Kidney Health Initiative | Kidney disease | Crossref funder ID: 100003066, Wikidata: Q6973913, nlx_158404, grid.419687.5, ISNI: 0000 0001 1958 7479 | https://ror.org/01n45xa04 | SCR_003990 | National Kidney Foundation | 2026-09-12 12:56:06 | 18 | ||||||
|
MediBeacon Resource Report Resource Website 10+ mentions |
MediBeacon (RRID:SCR_003987) | MediBeacon | commercial organization | A commercial optical diagnostic company focused on providing clinicians with critical information to improve patient care. The Optical Renal Function Monitor (ORFM) is their first product platform and is focused on real-time, easy to use, and cost-effective monitoring of kidney function. Their non-invasive monitoring technology works in a similar fashion to pulse oximetry by using a light sensor placed on the skin. After the sensor has been placed, a proprietary biocompatible tracer is administered. The system can then monitor the patient''s real-time point-of-care kidney function. This information will allow for earlier detection of renal issues enabling clinicians to provide earlier, and hence more effective interventions. MediBeacon has created a research grade technique that is clinically applicable for real-time point-of-care Glomerular Filtration Rate measurement (mGFR). MediBeacon has invented a fluorescent tracer agent (MB-102) that is removed from the blood exclusively by the GFR mechanism of the kidneys. Together with their non-invasive detection device, this will deliver a real-time point-of-care measurement of GFR. | kidney function, kidney, patient care, clinical, nephrology, glomerular filtration rate, medical device |
is related to: Kidney Health Initiative is parent organization of: MediBeacon Studio Software |
Kidney disease | nlx_158398 | SCR_003987 | MediBeacon LLC | 2026-09-12 12:56:06 | 33 | |||||||
|
DaVita Resource Report Resource Website 10+ mentions |
DaVita (RRID:SCR_003980) | DaVita | commercial organization | Healthcare company. Commercial dialysis provider with offerings that include in-center hemodialysis, in-center nocturnal dialysis, peritoneal dialysis, home hemodialysis, vascular access management, chronic kidney disease education, and renal diet assistance. Information on dialysis and chronic kidney disease, including informative articles and animated learning modules, and recipes for the dialysis diet are also available. Take advantage of their discussion forum, Find a Dialysis Center tool, DaVita GFR Calculator and more. | dialysis, health care, kidney, diet, clinical, administrative service | is related to: Kidney Health Initiative | Chronic kidney disease, End stage renal disease | nlx_158385 | SCR_003980 | DaVita Inc, DaVita.com, DaVita Healthcare Partners Inc., DaVita Kidney Care, DaVita Inc. | 2026-09-12 12:56:06 | 35 | |||||||
|
FAST BioMedical Resource Report Resource Website 1+ mentions |
FAST BioMedical (RRID:SCR_003983) | commercial organization | A clinical stage company developing a timely, precise, and convenient method for measuring plasma volume and glomerular filtration rate (GFR). They focus on development and commercialization of a patented technology for quantifying clinically relevant parameters that have been challenging or impossible to measure in the past. The company is currently developing technology for quantifying volume status and kidney function in a clinically actionable timeframe. Their technology could have a significant impact on the treatment of patients with acute kidney injury (AKI) and chronic kidney disease (CKD). | clinical, kidney function, plasma volume, glomerular filtration rate, kidney | is related to: Kidney Health Initiative | Acute kidney injury, Chronic kidney disease | grid.505053.6, nlx_158390 | https://ror.org/04rmmkk14 | SCR_003983 | 2026-09-12 12:56:06 | 3 | ||||||||
|
ChemoCentryx Resource Report Resource Website 10+ mentions |
ChemoCentryx (RRID:SCR_003976) | commercial organization | A biopharmaceutical company focused exclusively on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. Each drug candidate is a small molecule designed to target a specific chemokine or chemo-attractant receptor, thereby blocking the inflammatory response driven by that particular chemokine while leaving the rest of the immune system unaffected., THIS RESOURCE IS NO LONGER IN SERVICE. Documented on September 16,2025. | biopharmaceutical, oral administration, medicine, small molecule, chemokine, chemo-attractant receptor, clinical, drug, oral drug | is related to: Kidney Health Initiative | Autoimmune disease, Inflammatory disorder, Cancer | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_158383, grid.452218.8, ISNI: 0000 0004 0408 7502 | https://ror.org/04gp12571 | SCR_003976 | ChemoCentryx Inc, ChemoCentryx Inc. | 2026-09-12 12:56:06 | 43 | ||||||
|
C. R. Bard Resource Report Resource Website 1+ mentions |
C. R. Bard (RRID:SCR_003975) | BARD, BCR | commercial organization | A multinational developer, manufacturer, and marketer of medical technologies specializing in the manufacture of vascular, urology, oncology and surgical specialty products. BARD pioneered the development of single-patient-use medical products for hospital procedures; today BARD is dedicated to pursuing technological innovations that offer superior clinical benefits while helping to reduce overall costs. Bard is perhaps best known for having introduced the Foley catheter. (Adapted from Wikipedia) | medical equipment, vascular, urology, oncology, surgical, medical technology, medical, clinical | is related to: Kidney Health Initiative | Cancer | nlx_158382 | SCR_003975 | C. R. Bard Inc., C.R. Bard Inc., C. R. Bard Inc, CR Bard, C.R. Bard Inc, C.R. Bard, CR Bard Inc. | 2026-09-12 12:56:06 | 2 | |||||||
|
ClinMet Resource Report Resource Website 1+ mentions |
ClinMet (RRID:SCR_003979) | ClinMet | commercial organization | THIS RESOURCE IS OUT OF SERVICE, documented on July 23, 2021.Organization that uses metabolomics to provide pharmaceutical companies with clinically relevant and practical insight into drug response and safety for renal and cardiovascular diseases, obesity and diabetes. Their combination of skills to achieve exhaustive understanding of a disease along with detailed clinical insights, signature panel of urine-based metabolomic biomarkers, proprietary metabolomics and computational expertise will accelerate the speed and success rate of drug development. ClinMet helps drug developers to efficiently transform promising compounds into safe and effective medicines. Their efficacy and toxicity indices enable pharmaceutical companies to make better clinical trial-related decisions and provide an increased understanding of a drug''s mechanism of action. | metabolomics, drug, mechanism of action, clinical, clinical trial, drug efficacy, toxicity, drug discovery, drug development, kidney, safety, efficacy, medicine | is related to: Kidney Health Initiative | nlx_158384 | SCR_003979 | Clinical Metabolomics Inc, Clinical Metabolomics Inc. | 2026-09-12 12:56:06 | 1 | ||||||||
|
BC Childrens Hospital Foundation Resource Report Resource Website 1+ mentions |
BC Childrens Hospital Foundation (RRID:SCR_003925) | BCCHF | institution | Funding resource that raises funds to support BC Children's Hospital, Sunny Hill Health Centre for Children and the Child and Family Research Institute. The Foundation also works with Sunny Hill's Board of Directors to manage the Sunny Hill Foundation for Children. In 2013, BC Children's Hospital Foundation received donations from more than 150,000 people and had revenues of over $83 million. | child, pediatric, clinical | grid.498685.e, Wikidata: Q4835281, ISNI: 0000 0001 1432 0695, nlx_158291 | https://ror.org/01xesb955 | SCR_003925 | BC Children's Hospital Foundation | 2026-09-12 12:56:05 | 2 | ||||||||
|
Institute of Cancer Research Resource Report Resource Website 10+ mentions |
Institute of Cancer Research (RRID:SCR_003912) | ICR | institution | Academic cancer research center, a postgrad college, and a charity in the United Kingdom that is making discoveries that defeat cancer. With their partners The Royal Marsden NHS Foundation Trust they form the largest comprehensive cancer center in Europe and perform high quality and original basic research and translational studies, with the aim of developing better treatments for the benefit of cancer patients worldwide. The ICR offers comprehensive, modern facilities for research and studentships supported by the Wellcome Trust, MRC, CRUK and EPSRC and the ICR''s own resources which are awarded on a competitive basis. The ICR offers postgraduate research degrees (MPhil, PhD and MD (Res)) and a modular postgraduate taught degree in oncology aimed at clinicians undertaking specialist training in the field of Clinical or Medical Oncology leading to a Postgraduate Certificate, Postgraduate Diploma or MSc in Oncology. | clinical, medical, oncology |
is related to: PREDECT has parent organization: University of London; London; United Kingdom is parent organization of: FLIGHT is parent organization of: MoKCa- Mutations of Kinases in Cancer |
Cancer | nlx_158259, grid.18886.3f, Wikidata: Q6039999, ISNI: 0000 0001 1271 4623 | https://ror.org/043jzw605 | SCR_003912 | The Institute of Cancer Research | 2026-09-12 12:56:05 | 12 | ||||||
|
Orion Resource Report Resource Website 10+ mentions |
Orion (RRID:SCR_003911) | Orion | commercial organization | A globally operating Finnish developer, manufacturer and marketer of human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. They are continuously developing new drugs and treatment methods. Pharmaceutical RD focuses on central nervous system drugs, oncology and critical care drugs, and Easyhaler pulmonary drugs. | pharmaceutical, drug, diagnostic test, diagnostic, central nervous system, drug, oncology, critical care, pulmonary, central nervous system drug, pulmonary drug, cancer, veterinary drug, medicine, clinical, hygiene monitoring |
is related to: MIP-DILI is related to: NEWMEDS is related to: ORBITO is related to: PREDECT |
Cancer, Asthma, Alzheimer's disease, Parkinson's disease, Breast cancer, Prostate cancer | nlx_158257 | SCR_003911 | Orion Corporation, Orion Pharma | 2026-09-12 12:56:05 | 34 | |||||||
|
Simcyp Resource Report Resource Website 100+ mentions |
Simcyp (RRID:SCR_003944) | commercial organization | Research based company providing predictive pharmacokinetic and pharmacodynamic tools, workshops and consultancy services. Their user-friendly simulator and databases predict drug absorption, clearance, distribution and metabolic drug-drug interactions from in vitro data. Simcyp's clients include major global pharmaceutical and bioscience companies, leading academic institutes and regulatory authorities. These clients form the Simcyp Consortium, which together with independent International Scientific Advisory Board, guide scientific development at Simcyp.Simcyp was acquired by Certara in 2012. | modelling, simulation, pharmaceutical, drug development, pharmacokinetics, pharmacodynamics, population, drug-drug interaction, clinical, infant, child, adult, drug, interaction, database, FASEB list |
is related to: ORBITO is related to: Certara |
European Union FP6 ; UK Department of Trade and Industry |
nlx_158337 | SCR_003944 | Simcyp Ltd, Simcyp Limited | 2026-09-12 12:56:05 | 177 | ||||||||
|
Biomedical Diagnostics Institute Resource Report Resource Website |
Biomedical Diagnostics Institute (RRID:SCR_004022) | BDI | data or information resource, portal, topical portal | An academic-business-clinical partnership that sponsors research programs focused on the development of next-generation biomedical diagnostic devices. They aim to transform healthcare by pioneering advances in the science and technology of diagnostics and by translating these advances into clinical use. Building on key scientific insights, the BDI will now apply its established capabilities to create integrated Point-of-Care solutions, which will have major impacts on diagnosing disease and sustaining human health. | device development, product development, device, diagnostic, microfluidics, molecular assay, signal detection, biomarker, custom antibody, clinical, healthcare, diagnostic device, antibody, consortium |
is listed by: Consortia-pedia is related to: Dublin City University; Dublin; Ireland is related to: National University of Ireland; Galway; Ireland is related to: Royal College of Surgeons in Ireland; Dublin; Ireland is related to: Trinity College Dublin; Dublin; Ireland has parent organization: Dublin City University; Dublin; Ireland |
Science Foundation Ireland ; Industry partners |
nlx_158448 | SCR_004022 | 2026-09-12 12:56:07 | 0 | ||||||||
|
Association for the Advancement of Medical Instrumentation Resource Report Resource Website 1+ mentions |
Association for the Advancement of Medical Instrumentation (RRID:SCR_003973) | AAMI | nonprofit organization | A nonprofit organization made up of a diverse community of healthcare technology professionals that support the healthcare community in the development, management, and use of safe and effective medical technology. It is the primary source of consensus and timely information on medical instrumentation and technology. * AAMI is the primary resource for the industry, the professions, and government for national and international standards. * AAMI provides multidisciplinary leadership and programs that enhance the ability of the professions, healthcare institutions, and industry to understand, develop, manage, and use medical instrumentation and related technologies safely and effectively. * AAMI helps members: contain costs, keep informed of new technology and policy developments, add value in healthcare organizations, and improve professional skills and enhance patient care. * AAMI provides a unique and critical forum for members who cover a complete range of interests, from clinical and biomedical engineers and technicians, physicians, nurses, and hospital administrators, to educators and researchers, manufacturers, distributors, government representatives and other healthcare professionals with an interest in medical devices. * AAMI fulfills its mission through: ** continuing education, conferences ** certification of healthcare technical specialists ** the publication of technical documents, periodicals, books, software. | safety, efficacy, medical instrument, medical device, clinical, training resource, patient care, medical technology | is related to: Kidney Health Initiative | ISNI: 0000 0000 8633 8985, nlx_158380, grid.489418.8, Wikidata: Q4809544 | https://ror.org/023vxq234 | SCR_003973 | 2026-09-12 12:56:06 | 1 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the NIF Resources search. From here you can search through a compilation of resources used by NIF and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that NIF has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on NIF then you can log in from here to get additional features in NIF such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into NIF you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
Welcome to the Neuroscience Information Framework Project, designed to serve the biomedical research community. NIF maintains the largest searchable collection of neuroscience data, the largest catalog of biomedical resources, and the largest ontology for neuroscience on the web. We welcome all feedback and suggestions and are actively looking for resource providers to make their resources accessible through NIF. Learn about the tools available to help you share your data and discover a dynamic inventory of Web-based neuroscience resources.
